查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1618742

神经调节市场：按技术、按应用划分 - 2025-2030 年全球预测

Neuromodulation Market by Technology (Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation), Application (Chronic Pain, Dystonia, Essential Tremor) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年神经调节市场价值为77.6亿美元，预计到2024年将达到86.1亿美元，复合年增长率为11.50%，到2030年将达到166.2亿美元。

作为医学领域的先锋领域，调查方法包括直接影响神经以达到治疗效果的技术和方法，透过电刺激或标靶药物传递来改变神经活动。这种需求源于日益增加的神经系统疾病、慢性疼痛综合症和人口老化，从而产生了对有效管理解决方案的需求。应用包括慢性疼痛管理、癫痫、帕金森氏症、忧郁症和目标肌肉疾病。最终使用情境通常包括使用脊髓刺激设备、迷走神经刺激设备、深层脑部刺激器等的医院、诊所和居家照护环境。市场动态表明，技术进步、意识提升和医疗保健支出增加等关键影响因素正在推动成长。微创手术的增加提供了利润丰厚的可能性，并代表了新市场进入的前沿。此外，医疗保健框架不断完善的新兴国家也带来了尚未开发的商机。然而，高昂的设备成本、复杂的法规环境以及潜在的副作用等限制限制了市场的快速扩张。另一个问题是，现有公司正在获得先发优势，并阻碍新进入。在创新方面，穿戴式神经调节器和透过人工智慧实现的个人化治疗方法凸显了丰富的研究途径，有望颠覆传统做法。此外，将物联网整合到神经系统应用中进行远端监控有可能重新定义患者的互动和结果。市场的动态性和保守性要求产品开发和策略伙伴关係关係的敏捷性，以占领市场占有率。为了利用这些机会，鼓励企业投资符合监管合规性的强有力的倡议，并强调与高科技公司的合作，以整合数位技术的进步。总体而言，神经调节市场面临障碍，但在连接创新解决方案和临床疗效以实现持续业务成长方面存在巨大潜力。

主要市场统计
基准年[2023] 77.6亿美元
预测年份 [2024] 86.1亿美元
预测年份 [2030] 166.2亿美元
复合年增长率（%） 11.50%

市场动态：揭示快速发展的神经调节市场的关键市场洞察

供需的动态交互作用正在改变神经调节市场。了解这些不断变化的市场动态可以帮助公司做出明智的投资决策、改善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 世界人口老化加剧和神经系统疾病蔓延
    • 神经刺激系统和神经调节解决方案的研究计划和临床测试
    • 政府努力扩大神经系统疾病和失调的治疗方法机会
  • 市场限制因素
    • 神经调节和神经刺激设备系统发生产品召回
  • 市场机会
    • 优化神经调节策略效率与安全性的创新
    • 世界各地正在核准神经调节设备和治疗方法
  • 市场问题
    • 该技术的侵入性和技术限制

波特五力：驾驭神经调节市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解神经调节市场的外在影响

外部宏观环境因素在塑造神经调节市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解神经调节市场的竞争格局

对神经调节市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵：神经调节市场供应商绩效评估

FPNV定位矩阵是评估神经调节市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：规划神经调节市场的成功之路

神经调节市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开发：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化和神经系统疾病在世界各地变得越来越普遍。
      • 神经刺激系统和解决方案的研究倡议和临床测试
      • 政府努力扩大神经系统疾病和失调的治疗方法范围
    • 抑制因素
      • 神经调节和神经刺激设备或系统的产品回收数量
    • 机会
      • 优化神经调节策略效率与安全性的创新
      • 世界各地正在核准神经调节设备和治疗方法
    • 任务
      • 该技术的侵入性和技术限制
  • 市场区隔分析
    • 技术：对于运动障碍和精神疾病的深部脑部刺激疗法的需求日益增长。
    • 用途：全球帕金森氏症发病率增加
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章神经调节市场：依技术分类

  • 介绍
  • 脑深部电刺激疗法
  • 胃刺激
  • 荐椎神经刺激
  • 脊髓刺激
  • 迷走神经刺激

第七章神经调节市场：依应用分类

  • 介绍
  • 慢性疼痛
  • 肌张力不全症
  • 自发性震颤
  • 胃轻瘫
  • 强迫性精神官能症
  • 帕金森氏症
  • 难治性癫痫
  • 抗治疗性忧郁症
  • 尿失禁

第八章美洲神经调节市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太神经调节市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲/中东/非洲神经调节市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • GrayMatters Health 在美国推出经 FDA核准的新的自我神经调节 PTSD治疗方法
    • Reddy 博士在印度推出用于偏头痛管理的可穿戴设备
    • Galderma 在 Liquid实况活动中展示了大胆的神经调节雄心
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • BioControl by Merck
  • BioElectronics Corporation
  • Boston Scientific Corporation
  • Dr Reddys Laboratories Limited
  • EndoStim, Inc.
  • Galderma SA
  • GrayMatters Health
  • Impulse Dynamics
  • Livanova
  • Mainstay Medical
  • Medtronic PLC
  • MicroTransponde
  • NeuroMetrix
  • Neuronetics, Inc.
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • Nevro Corp.
  • Saluda Medical
  • SceneRay Corporation, Limited
  • Soterix Medical
  • Synapse Biomedical
Product Code: MRR-036C5CF3B4DB

The Neuromodulation Market was valued at USD 7.76 billion in 2023, expected to reach USD 8.61 billion in 2024, and is projected to grow at a CAGR of 11.50%, to USD 16.62 billion by 2030.

Neuromodulation, a pioneering domain in the medical field, encompasses technologies and methodologies that directly act upon nerves to achieve a therapeutic effect, thus altering nerve activity through targeted delivery of electrical stimulation or pharmaceutical agents. Its necessity arises from rising neurological disorders, chronic pain syndromes, and an aging population, creating an imperative for effective management solutions. The application spectrum includes chronic pain management, epilepsy, Parkinson's disease, depression, and targeted muscle disorders. End-use scenarios often feature hospitals, clinics, and in-home care settings that leverage spinal cord stimulators, vagus nerve stimulators, and deep brain stimulators. Market dynamics reveal key influencers such as technological advancements, increasing patient awareness, and heightened healthcare expenditure which boost growth. The escalation of minimally invasive surgeries offers lucrative potential and marks a frontier for new market entrants. Furthermore, emergent economies with improving healthcare frameworks present untapped opportunities. However, limitations such as high device costs, complex regulatory environments, and potential side effects restrict rapid market expansion. Challenges also stem from first-mover advantages held by established players, inhibiting newer entrants. Innovatively, wearable neuromodulators and AI-driven personalization of treatment regimens highlight fertile research avenues poised to disrupt traditional practices. Additionally, the integration of IoT for remote monitoring in neural applications could redefine patient interactions and outcomes. The market holds a dynamic yet conservative nature, where nimbleness in product development and strategic partnerships is critical to captivate market share. Businesses are encouraged to invest in robust R&D initiatives that align with regulatory compliances to harness these opportunities, emphasizing collaborations with tech firms to integrate digital advancements. Overall, while the neuromodulation market faces hurdles, its vast potential lies in bridging innovative solutions with clinical efficacy for sustained business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 7.76 billion
Estimated Year [2024] USD 8.61 billion
Forecast Year [2030] USD 16.62 billion
CAGR (%) 11.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neuromodulation Market

The Neuromodulation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the aging population across the world and prevalence of neurological disorders
    • Research initiatives and clinical trials for neurostimulation systems and neuromodulation solutions
    • Government initiatives to expand access to therapies for neurological diseases and disorders
  • Market Restraints
    • Incidences of product recall of neuromodulation and neurostimulation devices or systems
  • Market Opportunities
    • Innovations to optimize the efficiency and safety of neuromodulation strategies
    • Ongoing approvals for neuromodulation devices and treatments across the world
  • Market Challenges
    • Invasiveness and technical limitations of the technology

Porter's Five Forces: A Strategic Tool for Navigating the Neuromodulation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neuromodulation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neuromodulation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neuromodulation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neuromodulation Market

A detailed market share analysis in the Neuromodulation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neuromodulation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neuromodulation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neuromodulation Market

A strategic analysis of the Neuromodulation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neuromodulation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BioControl by Merck, BioElectronics Corporation, Boston Scientific Corporation, Dr Reddys Laboratories Limited, EndoStim, Inc., Galderma S.A., GrayMatters Health, Impulse Dynamics, Livanova, Mainstay Medical, Medtronic PLC, MicroTransponde, NeuroMetrix, Neuronetics, Inc., NeuroPace, Inc., NeuroSigma, Inc., Nevro Corp., Saluda Medical, SceneRay Corporation, Limited, Soterix Medical, and Synapse Biomedical.

Market Segmentation & Coverage

This research report categorizes the Neuromodulation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, and Vagus Nerve Stimulation.
  • Based on Application, market is studied across Chronic Pain, Dystonia, Essential Tremor, Gastroparesis, Obsessive Compulsive Disorder, Parkinson's Disease, Refractory Epilepsy, Treatment Resistant Depression, and Urinary Fecal Incontinence.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the aging population across the world and prevalence of neurological disorders
      • 5.1.1.2. Research initiatives and clinical trials for neurostimulation systems and neuromodulation solutions
      • 5.1.1.3. Government initiatives to expand access to therapies for neurological diseases and disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recall of neuromodulation and neurostimulation devices or systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations to optimize the efficiency and safety of neuromodulation strategies
      • 5.1.3.2. Ongoing approvals for neuromodulation devices and treatments across the world
    • 5.1.4. Challenges
      • 5.1.4.1. Invasiveness and technical limitations of the technology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Increasing need for deep brain stimulation therapies for movement disorders and psychiatric issues
    • 5.2.2. Application: Rising incidences of Parkinson's disease across the world
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neuromodulation Market, by Technology

  • 6.1. Introduction
  • 6.2. Deep Brain Stimulation
  • 6.3. Gastric Stimulation
  • 6.4. Sacral Nerve Stimulation
  • 6.5. Spinal Cord Stimulation
  • 6.6. Vagus Nerve Stimulation

7. Neuromodulation Market, by Application

  • 7.1. Introduction
  • 7.2. Chronic Pain
  • 7.3. Dystonia
  • 7.4. Essential Tremor
  • 7.5. Gastroparesis
  • 7.6. Obsessive Compulsive Disorder
  • 7.7. Parkinson's Disease
  • 7.8. Refractory Epilepsy
  • 7.9. Treatment Resistant Depression
  • 7.10. Urinary Fecal Incontinence

8. Americas Neuromodulation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Neuromodulation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Neuromodulation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. GrayMatters Health Launches New FDA-Cleared Self-Neuromodulation PTSD Therapy in the United States
    • 11.3.2. Dr. Reddy's Unveils Wearable for Migraine Management in India
    • 11.3.3. Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BioControl by Merck
  • 3. BioElectronics Corporation
  • 4. Boston Scientific Corporation
  • 5. Dr Reddys Laboratories Limited
  • 6. EndoStim, Inc.
  • 7. Galderma S.A.
  • 8. GrayMatters Health
  • 9. Impulse Dynamics
  • 10. Livanova
  • 11. Mainstay Medical
  • 12. Medtronic PLC
  • 13. MicroTransponde
  • 14. NeuroMetrix
  • 15. Neuronetics, Inc.
  • 16. NeuroPace, Inc.
  • 17. NeuroSigma, Inc.
  • 18. Nevro Corp.
  • 19. Saluda Medical
  • 20. SceneRay Corporation, Limited
  • 21. Soterix Medical
  • 22. Synapse Biomedical

LIST OF FIGURES

  • FIGURE 1. NEUROMODULATION MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROMODULATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROMODULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROMODULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NEUROMODULATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NEUROMODULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROMODULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROMODULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROMODULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROMODULATION MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROMODULATION MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROMODULATION MARKET SIZE, BY GASTRIC STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROMODULATION MARKET SIZE, BY SACRAL NERVE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROMODULATION MARKET SIZE, BY SPINAL CORD STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROMODULATION MARKET SIZE, BY VAGUS NERVE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROMODULATION MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROMODULATION MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROMODULATION MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROMODULATION MARKET SIZE, BY GASTROPARESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROMODULATION MARKET SIZE, BY OBSESSIVE COMPULSIVE DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROMODULATION MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROMODULATION MARKET SIZE, BY REFRACTORY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROMODULATION MARKET SIZE, BY TREATMENT RESISTANT DEPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEUROMODULATION MARKET SIZE, BY URINARY FECAL INCONTINENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES NEUROMODULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. INDIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. INDONESIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. INDONESIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. JAPAN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. JAPAN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MALAYSIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. MALAYSIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. PHILIPPINES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. PHILIPPINES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. SINGAPORE NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. SINGAPORE NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. SOUTH KOREA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. SOUTH KOREA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. TAIWAN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. TAIWAN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. THAILAND NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. THAILAND NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. VIETNAM NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. VIETNAM NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. DENMARK NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. DENMARK NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. EGYPT NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. EGYPT NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. FINLAND NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. FINLAND NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. FRANCE NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. FRANCE NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. GERMANY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. GERMANY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ISRAEL NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. ISRAEL NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. ITALY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. ITALY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. NETHERLANDS NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. NETHERLANDS NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. NIGERIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. NIGERIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. NORWAY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. NORWAY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. POLAND NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. POLAND NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. QATAR NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. QATAR NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. RUSSIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. RUSSIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SAUDI ARABIA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SAUDI ARABIA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH AFRICA NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH AFRICA NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SPAIN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. SPAIN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SWEDEN NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. SWEDEN NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SWITZERLAND NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SWITZERLAND NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. TURKEY NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. TURKEY NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED ARAB EMIRATES NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED KINGDOM NEUROMODULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NEUROMODULATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 110. NEUROMODULATION MARKET, FPNV POSITIONING MATRIX, 2023